In cancer research, several enzymes are commonly used as biomarkers to assess various aspects of cancer development, progression, and treatment response. Some important examples include: 1) Telomerse. Telomerase is an enzyme that helps maintain the ends of telomeres, the protective caps at the ends of chromosomes. Increased telomerase activity is often associated with cancer cells, as it enables them to divide indefinitely, a cancer hallmark. Detection of telomerase activity can be used as a diagnostic and prognostic marker for certain types of cancers; 2) Matrix metalloproteinases (MMPs). MMPs are a family of enzymes involved in the breakdown and remodelling of the extracellular matrix (ECM), which plays a critical role in tumour invasion and metastasis. Elevated levels of specific MMPs, such as MMP-2 and MMP-9, have been associated with various types of cancers, making them potential biomarkers for tumour aggressiveness; 3) Carbonic anhydrase IX (CA-IX). CA-IX is an enzyme that plays a role in maintaining pH balance within cells. It is overexpressed in several types of solid tumours and is associated with tumour hypoxia. CA-IX expression can therefore serve as a biomarker for hypoxic regions within tumours and has been used to predict patient prognosis and response to certain therapies; 4) Prostate-specific antigen (PSA). PSA is an enzyme produced by the prostate gland, and its levels detected in blood samples are often elevated in prostate cancer patients. PSA is widely used therefore as a screening tool for prostate cancer and as a biomarker to monitor disease progression and treatment response; 5) Alkaline phosphatase (ALP). ALP is an enzyme involved in various cellular processes, including bone formation. Elevated ALP levels in the blood can indicate bone metastasis in several types of cancers, such as prostate, breast, and lung cancer; 6) Deoxycytidine kinase (dCK). dCK is an enzyme involved in the activation of certain anticancer drugs, including nucleoside analogues. Assessing dCK levels can provide insights into drug sensitivity and resistance in cancer cells; 7) Lactate dehydrogenase (LDH) is an enzyme that is found in various tissues throughout the body, including the cells of the heart, liver, kidneys, and skeletal muscles. LDH plays a crucial role in the conversion of lactate to pyruvate during cellular energy metabolism. LDH levels can serve as a prognostic indicator in some cancers. High LDH levels at the time of diagnosis or during treatment can indicate a more aggressive disease and a poorer prognosis, whilst monitoring LDH levels over time can help assess the response to treatment and disease progression. We provide a comprehensive product range of research reagents for studying enzymes, including Alkaline Phosphatase antibodies, NSE antibodies, MMP9 antibodies, MMP9 ELISA Kits, and MMP3 ELISA Kits. Explore our full enzymes product range below and discover more, for less. Alternatively, you can explore our MMPs, Phosphatases, and Neuron Specific Enolase product ranges.